Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2015
03/05/2015WO2015031815A2 Antibodies and assays for detection of folate receptor 1
03/05/2015WO2015031808A2 Diagnostic methods and compositions for treatment of glioblastoma
03/05/2015WO2015031787A2 Enhancing immunity to tuberculosis
03/05/2015WO2015031698A1 Site-specific antibody conjugation methods and compositions
03/05/2015WO2015031667A2 Gitr antigen binding proteins
03/05/2015WO2015031645A1 Monoclonal antibodies to human 14-3-3 epsilon and human 14-3-3 epsilon sv
03/05/2015WO2015031578A1 Hgf assay
03/05/2015WO2015031541A1 Novel sez6 modulators and methods of use
03/05/2015WO2015031376A1 Scaffolds containing cytokines for tissue engineering
03/05/2015WO2015030701A1 Fully human antibodies against human rankl
03/05/2015WO2015030539A1 An anti serum albumin fab-effector moiety fusion construct, and the preparing method thereof
03/05/2015WO2015028694A1 Method for the screening of molecules useful in the treatment and/or prevention of alzheimer's disease
03/05/2015WO2015028666A1 Neutralizing antibody or a fragment thereof specifically binding primate gm-csf for use in the treatment and/or prevention of psoriasis
03/05/2015WO2015028657A1 Antibodies neutralizing gm-csf for use in the treatment of rheumatoid arthritis or as analgesics
03/05/2015WO2015028484A1 Antibodies for diagnosis of acute myeloid leukemia
03/05/2015WO2015028478A1 Novel influenza antigens and antibodies
03/05/2015WO2015028455A1 Antibodies
03/05/2015WO2015028454A2 Method for the treatment of fibrotic disease
03/05/2015WO2015028444A1 Anti cd30 chimeric antigen receptor and its use
03/05/2015WO2015028027A1 Anti-ADAM12 antibodies for the treatment of cancer
03/05/2015WO2015027906A1 Bifunctional fusion protein, preparation method therefor, and use thereof
03/05/2015WO2015027820A1 Use of human nectin-2 protein
03/05/2015US20150067897 Genetically modified non-human mammals and cells
03/05/2015US20150065693 Composition for prophylaxis or treatment of vascular or cardiac valvular calcification comprising dipeptidyl peptidase-4 inhibitor
03/05/2015US20150065692 Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies
03/05/2015US20150065691 Anti-Cancer Antibodies With Reduced Complement Fixation
03/05/2015US20150065690 Modified antibody regions and uses thereof
03/05/2015US20150065385 Reagents and methods for detecting protein crotonylation
03/05/2015US20150065380 Brain somatic mutations associated to epilepsy and uses thereof
03/05/2015US20150064727 Ectoparasite Detection
03/05/2015US20150064725 Engineered nucleic acids and methods of use thereof
03/05/2015US20150064721 Composition and kit for separating cancer cell, and method of separating cancer cell by using the composition and kit
03/05/2015US20150064716 Goodpasture Antigen Binding Protein and Its Detection
03/05/2015US20150064715 Urinary biomarkers of renal and mitochondrial dysfunction
03/05/2015US20150064236 Modified polynucleotides for the production of proteins
03/05/2015US20150064212 Process for the preparation and use of a bivalent vaccine against morphine-heroin addiction
03/05/2015US20150064208 Polyvalent chimeric ospc vaccinogen and diagnostic antigen
03/05/2015US20150064207 Epsilon toxin epitopes from clostridium perfringens with reduced toxicity
03/05/2015US20150064205 Enhancement of pathogen-specific memory th17 cell responses
03/05/2015US20150064204 Gitr antigen binding proteins
03/05/2015US20150064203 Anticancer agent
03/05/2015US20150064202 Humanized and chimeric anti-factor c3 antibodies and uses thereof
03/05/2015US20150064201 Antigen binding proteins to oncostatin m (osm)
03/05/2015US20150064198 Enhancing Immunity to Tuberculosis
03/05/2015US20150064197 Methods of modulating immunity
03/05/2015US20150064195 Uses and compositions for treatment of rheumatoid arthritis
03/05/2015US20150064193 Methods of treating psoriatic arthritis (psa) using il-17 antagonists and psa response or non-response alleles
03/05/2015US20150064192 Mammalian cell surface antigens; related reagents
03/05/2015US20150064191 Anti-c-met-antibody formulations
03/05/2015US20150064190 Antibodies to tumor endothelial marker 7r
03/05/2015US20150064189 Method of Treating Cancer with DLL4 Antagonist and Chemotherapeutic Agent
03/05/2015US20150064188 Polypeptide structural motifs associated with cell signaling activity
03/05/2015US20150064187 Fibrosis suppression by inhibiting integrin alpha-8 beta-1 function
03/05/2015US20150064186 Methods of treating liver conditions using notch2 antagonists
03/05/2015US20150064185 Drug compositions, fushions and conjugates
03/05/2015US20150064184 Methods and compositions for increasing arylsulfatase a activity in the cns
03/05/2015US20150064183 Targeted therapeutic proteins
03/05/2015US20150064182 Stabilized single domain antibodies
03/05/2015US20150064181 Antisense conjugates for decreasing expression of dmpk
03/05/2015US20150064179 Humanized anti-il 10 antibodies for the treatment of systemic lupus erythematosus (sle)
03/05/2015US20150064178 Diagnostic methods and compositions for treatment of glioblastoma
03/05/2015US20150064177 Therapeutic uses of humanized antibodies against alpha-4 integrin
03/05/2015US20150064176 Methods for treating conditions associated with masp-2 dependent complement activation
03/05/2015US20150064174 Neutralizing antibody for epstein barr virus-associated disease
03/05/2015US20150064170 Antibody Preparations
03/05/2015US20150064169 Protease-regulated antibodies
03/05/2015US20150064168 Cadherin-11 Inhibitors and Methods of Use Thereof
03/05/2015US20150064132 Treatment Methods for Rheumatoid Arthritis
03/04/2015EP2843051A1 Anti-human cd69 antibody, and use thereof for medical purposes
03/04/2015EP2843048A1 NOVEL INTEGRIN alpha9beta1 LIGAND AND USES THEREOF
03/04/2015EP2842968A1 Anti-IL-6 antibodies, compositions, methods and uses
03/04/2015EP2842967A1 Pegylated amyloid beta fab
03/04/2015EP2842571A1 Antibodies directed to GPNMB and uses thereof
03/04/2015EP2842565A1 Antibody-mediated disruption of quorum sensing in bacteria
03/04/2015EP2841459A1 Anti-cd22 antibodies
03/04/2015EP2841458A1 Modified antibody regions and uses thereof
03/04/2015EP2841457A1 Anti-robo4-antibody
03/04/2015EP2841456A1 Human cd30 ligand antigen binding proteins
03/04/2015EP2841455A1 Antibodies against cd106 (vcam-1)
03/04/2015EP2841454A1 Anti-pdgf-c antibodies
03/04/2015EP2841453A1 Humanized and chimeric anti-factor c3 antibodies and uses thereof
03/04/2015EP2841452A1 Modified glycoproteins
03/04/2015EP2841099A1 Combination of cd37 antibodies with bendamustine
03/04/2015EP2841093A2 Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
03/04/2015EP2841082A1 Protease-regulated antibodies
03/03/2015US8969539 Expression vectors
03/03/2015US8969536 Torque teno virus (TTV) isolates and compositions
03/03/2015US8969531 Anti-CD80 antibody
03/03/2015US8969530 Anti-clathrin heavy chain monoclonal antibody for inhibition of tumor angiogenesis and growth and application thereof
03/03/2015US8969529 Methods and compositions based on shiga toxin type 2 protein
03/03/2015US8969528 Antibodies to hepatocyte growth factor activator
03/03/2015US8969527 Recurrent gene fusions in prostate cancer
03/03/2015US8969526 Antibody Fc variants
03/03/2015US8969525 Hydroxycholesterol immunoassay
03/03/2015US8969519 Compositions and methods for brown fat induction and activity using FNDC5
03/03/2015US8969518 B7 family member zB7H6 and related compositions and methods
03/03/2015US8969311 Polypeptide having antibacterial activity and angiogenesis-inducing activity and wound-healing drug containing said polypeptide
03/03/2015US8969301 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-tRNA synthetases
03/03/2015US8969082 Expression of surrogate light chains
03/03/2015US8969066 Induction of flocculation in photosynthetic organisms
1 2 3 4 5 6 7 8 9 10 11 ... 1494